` 0HQ1 (Brooks Automation Inc) vs S&P 500 Comparison - Alpha Spread

0HQ1
vs
S&P 500

Over the past 12 months, 0HQ1 has underperformed S&P 500, delivering a return of -39% compared to the S&P 500's 10% growth.

Stocks Performance
0HQ1 vs S&P 500

Loading

Performance Gap
0HQ1 vs S&P 500

Loading
0HQ1
S&P 500
Difference

Performance By Year
0HQ1 vs S&P 500

Loading
0HQ1
S&P 500
Add Stock

Competitors Performance
Brooks Automation Inc vs Peers

S&P 500
0HQ1
ASML
AMAT
LRCX
KLAC
Add Stock

Brooks Automation Inc
Glance View

Economic Moat
None
Market Cap
330.8B USD
Industry
Semiconductors

Brooks Automation Inc., a company that has sculpted a notable niche within the world of advanced automation and life sciences, stands as a testament to strategic evolution and innovation. Originally carved from the industrial stone of automation technology, the company initially served the semiconductor industry by providing sophisticated automation systems and engineered solutions. This foundation laid the groundwork for Brooks to create and provide essential high-precision robotics, vacuum, and cryogenic solutions that enable the efficient functioning of chip manufacturing processes. As the industry progressed and demanded even more advanced systems, Brooks steadfastly adapted, implementing cutting-edge robotics and software structures that cemented its standing as a linchpin in semiconductor production. But the journey of Brooks Automation doesn’t halt at semiconductors. Recognizing the burgeoning potential of life sciences, the company strategically expanded into this sector, leveraging its automation expertise in a transformative pivot. They ventured into providing essential tools and systems for biological sample management and genomic services. This diversification, particularly through its life sciences division — now known as Azenta Life Sciences — caters to biopharmaceutical companies by offering solutions that significantly streamline the intricate processes of sample management. From automated storage systems to state-of-the-art biorepositories, Brooks creatively monetizes its dual-branch expertise by delivering efficiency and precision across two critical industries, harmonizing technological prowess with evolving market needs.

0HQ1 Intrinsic Value
0.4422 USD
Overvaluation 99%
Intrinsic Value
Price
B
Back to Top